Creative Planning’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
NCM
SCM
CCC
ACM
VC
KCM
TCM
Creative Planning's ABEO Position: Q4 2025 in Review
Creative Planning sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 17,762 shares — an estimated $93.8K sold.
Creative Planning first reported a position in ABEO in Q4 2014 and held it in 19 quarters. The position peaked at $875K in Q3 2018. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.
- Creative Planning reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
- Creative Planning sold 17,762 Abeona Therapeutics shares in Q4 2025, an estimated $93.8K.
- Creative Planning first reported a position in Abeona Therapeutics in Q4 2014 and held it in 19 quarters.
- Creative Planning's Abeona Therapeutics position peaked at $875K in Q3 2018.
- 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.
Based on Creative Planning's 13F filing for Q4 2025, filed 17 Feb 2026.